How is the Apfel risk score calculated for postoperative nausea and vomiting (PONV) and what prophylactic regimen is recommended for each score?

Apfel Score for PONV: Calculation and Prophylactic Management

Calculating the Apfel Score

The Apfel score assigns one point for each of four independent risk factors: female gender, non-smoking status, history of PONV or motion sickness, and postoperative opioid use. 1

• Each factor contributes equally (1 point each) to a maximum score of 4 1
• The score stratifies patients into risk categories: 0-1 points = low risk, 2 points = moderate risk, 3-4 points = high risk 2, 1
• Without prophylaxis, baseline PONV incidence correlates with score: approximately 10% (score 0), 20% (score 1), 40% (score 2), 60% (score 3), and 80% (score 4) 3, 4

Prophylactic Antiemetic Regimen by Risk Category

For patients with Apfel score ≥2, prophylactic combination antiemetic therapy from different drug classes is strongly recommended, with 2 agents for moderate risk (score 2) and 2-3 agents for high risk (score 3-4). 1, 5

Low Risk (Score 0-1)

• No routine prophylaxis required 1
• Consider non-pharmacologic strategies only (see below) 1

Moderate Risk (Score 2)

• Administer 2 antiemetics from different drug classes 1, 5
• First-line combination: ondansetron 8 mg plus dexamethasone 8 mg 5
• Each single-class agent provides approximately 25% relative risk reduction; combination therapy is essential 5, 6

High Risk (Score 3-4)

• Administer 2-3 antiemetics from different drug classes 1, 5
• Standard triple therapy: ondansetron + dexamethasone + third agent from alternative class 1
• For patients predicted to fail standard dual prophylaxis, consider adding olanzapine 10 mg to ondansetron plus dexamethasone (reduces PONV from 63% to 26%, RR 0.40, p=0.008) 6

First-Line Antiemetic Drug Classes

Select from six validated drug classes for prophylaxis: 1

1. 5-HT3 receptor antagonists (ondansetron, granisetron, dolasetron, tropisetron, ramosetron) - reduce vomiting and rescue antiemetic use 2
2. Corticosteroids (dexamethasone 8 mg) 2, 5
3. Dopamine (D2) antagonists (droperidol, haloperidol, metoclopramide) - droperidol reduces nausea, vomiting, and rescue antiemetic use 2
4. Neurokinin-1 receptor antagonists 1
5. Antihistamines (promethazine) - reduces nausea and vomiting 2
6. Anticholinergics (scopolamine) 1

Non-Pharmacologic Risk Reduction Strategies

Implement these evidence-based anesthetic modifications to reduce baseline PONV risk: 1

• Use total intravenous anesthesia (TIVA) with propofol instead of volatile anesthetic gases 1, 2
• Avoid nitrous oxide 1, 2
• Implement opioid-sparing multimodal analgesia 1, 5
• Ensure adequate hydration with mildly positive fluid balance (approximately 2 ml/kg/h reduces PONV) 2, 1
• Consider preoperative carbohydrate loading 1, 2
• Minimize preoperative fasting duration 2

Rescue Antiemetic Treatment

If breakthrough PONV occurs despite prophylaxis, administer a rescue antiemetic from a DIFFERENT drug class than those used prophylactically. 1

• Using the same drug class for rescue significantly reduces effectiveness 1
• Select from the six first-line classes not previously administered 1

Clinical Implementation and Outcomes

Systematic implementation of Apfel-based risk stratification with standardized prophylaxis protocols significantly reduces PONV incidence and rescue antiemetic requirements, particularly in high-risk populations. 7, 8

• Structured protocols reduce relative PONV risk by 29% and rescue medication need by 26% 7
• Educational strategies emphasizing preoperative Apfel scoring decrease PONV incidence from 19.4% to 11.4% (p=0.034) 8
• Adherence to risk-stratified prophylaxis reduces PONV prevalence below predicted Apfel rates without increasing treatment costs 3, 4
• High-risk patients (score 3-4) benefit most from protocol adherence, with significant reductions in both PONV incidence (p<0.001) and rescue medication use (p=0.008) 7

Common Pitfalls to Avoid

• Do not withhold prophylaxis in moderate-risk patients (score 2) - they require dual therapy 1
• Do not use single-agent prophylaxis in high-risk patients - combination therapy is essential as each agent provides only ~25% risk reduction 5, 6
• Do not repeat the same antiemetic class for rescue treatment - this significantly reduces efficacy 1
• Do not rely solely on pharmacologic prophylaxis - anesthetic technique modifications (TIVA, avoid nitrous oxide, opioid-sparing) provide substantial additional benefit 1, 2
• Do not forget adequate hydration - hypovolemia increases splanchnic hypoperfusion and 5-HT3 release, directly causing PONV 2